Your browser doesn't support javascript.
Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era.
Vachon, Celine M; Norman, Aaron D; Prasad, Kavita; Jensen, Dan; Schaeferle, Gavin M; Vierling, Kristy L; Sherden, Meaghan; Majerus, Michelle R; Bews, Katherine A; Heinzen, Ethan P; Hebl, Amy; Yost, Kathleen J; Kennedy, Richard B; Theel, Elitza S; Ghosh, Aditya; Fries, Meghan; Wi, Chung-Il; Juhn, Young J; Sampathkumar, Priya; Morice, William G; Rocca, Walter A; Tande, Aaron J; Cerhan, James R; Limper, Andrew H; Ting, Henry H; Farrugia, Gianrico; Carter, Rickey E; Finney Rutten, Lila J; Jacobson, Robert M; St Sauver, Jennifer.
  • Vachon CM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Norman AD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Prasad K; Integrative Medicine, Zumbro Valley Health Center, Mayo Clinic, Rochester, MN.
  • Jensen D; Department of Health, Housing and Human Services Administration, Olmsted County Public Health, Mayo Clinic, Rochester, MN.
  • Schaeferle GM; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
  • Vierling KL; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
  • Sherden M; Department of Epidemiology, Surveillance and Preparedness Team, Olmsted County Public Health, Mayo Clinic, Rochester, MN.
  • Majerus MR; Administration, Hutchinson Health, Hutchinson, MN.
  • Bews KA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
  • Heinzen EP; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
  • Hebl A; Department of Human Resources, Olmsted County, Mayo Clinic, Rochester, MN.
  • Yost KJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Kennedy RB; Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, MN.
  • Theel ES; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, MN.
  • Ghosh A; Department of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA.
  • Fries M; University of Notre Dame, South Bend, IA.
  • Wi CI; Department of Precision Population Science Lab, Mayo Clinic, Rochester, MN.
  • Juhn YJ; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN.
  • Sampathkumar P; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN.
  • Morice WG; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN.
  • Rocca WA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Tande AJ; Department of Neurology and Women's Health Research Center, Mayo Clinic, Rochester, MN.
  • Cerhan JR; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN.
  • Limper AH; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Ting HH; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
  • Farrugia G; Department of Cardiology, Emory University, Atlanta, GA.
  • Carter RE; Division of Gastroenterology & Hepatology, Department of Medicine, Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
  • Finney Rutten LJ; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL.
  • Jacobson RM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • St Sauver J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Mayo Clin Proc Innov Qual Outcomes ; 6(6): 605-617, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2131838
ABSTRACT

Objective:

To estimate rates and identify factors associated with asymptomatic COVID-19 in the population of Olmsted County during the prevaccination era. Patients and

Methods:

We screened first responders (n=191) and Olmsted County employees (n=564) for antibodies to SARS-CoV-2 from November 1, 2020 to February 28, 2021 to estimate seroprevalence and asymptomatic infection. Second, we retrieved all polymerase chain reaction (PCR)-confirmed COVID-19 diagnoses in Olmsted County from March 2020 through January 2021, abstracted symptom information, estimated rates of asymptomatic infection and examined related factors.

Results:

Twenty (10.5%; 95% CI, 6.9%-15.6%) first responders and 38 (6.7%; 95% CI, 5.0%-9.1%) county employees had positive antibodies; an additional 5 (2.6%) and 10 (1.8%) had prior positive PCR tests per self-report or medical record, but no antibodies detected. Of persons with symptom information, 4 of 20 (20%; 95% CI, 3.0%-37.0%) first responders and 10 of 39 (26%; 95% CI, 12.6%-40.0%) county employees were asymptomatic. Of 6020 positive PCR tests in Olmsted County with symptom information between March 1, 2020, and January 31, 2021, 6% (n=385; 95% CI, 5.8%-7.1%) were asymptomatic. Factors associated with asymptomatic disease included age (0-18 years [odds ratio {OR}, 2.3; 95% CI, 1.7-3.1] and >65 years [OR, 1.40; 95% CI, 1.0-2.0] compared with ages 19-44 years), body mass index (overweight [OR, 0.58; 95% CI, 0.44-0.77] or obese [OR, 0.48; 95% CI, 0.57-0.62] compared with normal or underweight) and tests after November 20, 2020 ([OR, 1.35; 95% CI, 1.13-1.71] compared with prior dates).

Conclusion:

Asymptomatic rates in Olmsted County before COVID-19 vaccine rollout ranged from 6% to 25%, and younger age, normal weight, and later tests dates were associated with asymptomatic infection.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Mayo Clin Proc Innov Qual Outcomes Year: 2022 Document Type: Article Affiliation country: J.mayocpiqo.2022.10.001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines Language: English Journal: Mayo Clin Proc Innov Qual Outcomes Year: 2022 Document Type: Article Affiliation country: J.mayocpiqo.2022.10.001